There is a lot of resistance of pharmaceutical society against 'Incentive system for reducing pharmaceutical cost'

There is a lot of resistance of pharmaceutical society against 'Incentive system for reducing pharmaceutical cost' which is following countermeasure of Market based actual transaction price.

Existing Market based actual transaction price induced low price purchasing, but the new system is expected to reduce pharmaceutical cost additionally. However, the problem is that medical institution can ...